Noradrenaline reuptake inhibition impairs cortical output and limits endurance time

Medicine and Science in Sports and Exercise

Volumn 48, Issue 6, 2016, Pages 1014-1023

  Klass, Malgorzata ^a   Duchateau, Jacques ^a   Rabec, Samuel ^a   Meeusen, Romain ^b,c   Roelands, Bart ^b,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c JAMES COOK UNIVERSITY   (Australia)

^d RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

Author keywords

EMG; FATIGUE; ISOMETRIC CONTRACTIONS; KNEE EXTENSOR MUSCLES; REBOXETINE; TMS

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE; REBOXETINE;

DRUG EFFECTS; ELECTROMYOGRAPHY; ELECTROSTIMULATION; ENDURANCE; EXERCISE; HEART RATE; HUMAN; KNEE; MALE; MOTOR CORTEX; MUSCLE FATIGUE; MUSCLE ISOMETRIC CONTRACTION; PERCEPTION; PHYSIOLOGY; PYRAMIDAL TRACT; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

ADRENERGIC UPTAKE INHIBITORS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HEART RATE; HUMANS; ISOMETRIC CONTRACTION; KNEE; MALE; MORPHOLINES; MOTOR CORTEX; MUSCLE FATIGUE; PERCEPTION; PHYSICAL ENDURANCE; PHYSICAL EXERTION; PYRAMIDAL TRACTS; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84954509210     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000879     Document Type: Article

References (40)

1. Ament W, Verkerke GJ,. Exercise and fatigue. Sports Med. 2009; 39 (5): 389-422
2. Berchicci M, Menotti F, Macaluso A, Di Russo F,. The neurophysiology of central and peripheral fatigue during sub-maximal lower limb isometric contractions. Front Hum Neurosci. 2013; 7: 135
3. Berridge CW, Waterhouse BD,. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev. 2003; 42 (1): 33-84
4. Borg GA,. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14 (5): 377-81
5. Burnley M,. Estimation of critical torque using intermittent isometric maximal voluntary contractions of the quadriceps in humans. J Appl Physiol (1985). 2009; 106 (3): 975-83
6. Burnley M, Vanhatalo A, Jones AM,. Distinct profiles of neuromuscular fatigue during muscle contractions below and above the critical torque in humans. J Appl Physiol (1985). 2012; 113 (2): 215-23
7. Dell'Osso B, Palazzo MC, Oldani L, Altamura AC,. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. CNS Neurosci Ther. 2011; 17 (6): 723-32
8. Dinges DF, Powell JW,. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods. 1985; 17 (6): 652-5
9. Duchateau J, Balestra C, Carpentier A, Hainaut K,. Reflex regulation during sustained and intermittent submaximal contractions in humans. J Physiol. 2002; 541 (Pt 3): 959-67
10. Duchateau J, Enoka RM,. Neural adaptations with chronic activity patterns in able-bodied humans. Am J Phys Med Rehabil. 2002; 81 (11 Suppl): S17-27
11. Enoka RM, Baudry S, Rudroff T, Farina D, Klass M, Duchateau J,. Unraveling the neurophysiology of muscle fatigue. J Electromyogr Kinesiol. 2011; 21 (2): 208-19
12. Goodall S, Gonzalez-Alonso J, Ali L, Ross EZ, Romer LM,. Supraspinal fatigue after normoxic and hypoxic exercise in humans. J Physiol. 2012; 590 (Pt 11): 2767-82
13. Hajos M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH,. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev. 2004; 10 (1): 23-44
14. Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J,. Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol. 2009; 120 (12): 2040-54
15. Inghilleri M, Berardelli A, Cruccu G, Manfredi M,. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993; 466: 521-34
16. Klass M, Lévénez M, Enoka RM, Duchateau J,. Spinal mechanisms contribute to differences in the time to failure of submaximal fatiguing contractions performed with different loads. J Neurophysiol. 2008; 99 (3): 1096-104
17. Klass M, Roelands B, Lévénez M, Effects of noradrenaline and dopamine on supraspinal fatigue in well-Trained men. Med Sci Sports Exerc. 2012; 44 (12): 2299-308
18. Kluger BM, Krupp LB, Enoka RM,. Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology. 2013; 80 (4): 409-16
19. Lee SB, Beak SK, Park SH, Waterhouse BD, Lee HS,. Collateral projection from the locus coeruleus to whisker-related sensory and motor brain regions of the rat. J Comp Neurol. 2009; 514 (4): 387-402
20. Lévénez M, Garland SJ, Klass M, Duchateau J,. Cortical and spinal modulation of antagonist coactivation during a submaximal fatiguing contraction in humans. J Neurophysiol. 2008; 99 (2): 554-63
21. Lim J, Wu WC, Wang JJ, Detre JA, Dinges DF, Rao HY,. Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-Task effect. NeuroImage. 2010; 49 (4): 3426-35
22. Loh S, Lamond N, Dorrian J, Roach G, Dawson D,. The validity of psychomotor vigilance tasks of less than 10-minute duration. Behav Res Methods Instrum Comput. 2004; 36 (2): 339-46
23. Maluf KS, Enoka RM,. Task failure during fatiguing contractions performed by humans. J Appl Physiol (1985). 2005; 99 (2): 389-96
24. Marcora SM, Staiano W, Manning V,. Mental fatigue impairs physical performance in humans. J Appl Physiol (1985). 2009; 106 (3): 857-64
25. Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF,. Central fatigue: the serotonin hypothesis and beyond. Sports Med. 2006; 36 (10): 881-909
26. Mottram CJ, Jakobi JM, Semmler JG, Enoka RM,. Motor-unit activity differs with load type during a fatiguing contraction. J Neurophysiol. 2005; 93 (3): 1381-92
27. Plewnia C, Hoppe J, Hiemke C, Bartels M, Cohen LG, Gerloff C,. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett. 2002; 330 (3): 231-4
28. Qian S, Li M, Li G, Environmental heat stress enhances mental fatigue during sustained attention task performing: evidence from an ASL perfusion study. Behav Brain Res. 2015; 280: 6-15
29. Ridding MC, Taylor JL, Rothwell JC,. The effect of voluntary contraction on cortico-cortical inhibition in human motor cortex. J Physiol. 1995; 487 (Pt 2): 541-8
30. Roelands B, de Koning J, Foster C, Hettinga F, Meeusen R,. Neurophysiological determinants of theoretical concepts and mechanisms involved in pacing. Sports Med. 2013; 43 (5): 301-11
31. Roelands B, Goekint M, Heyman E, Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature. J Appl Physiol (1985). 2008; 105 (1): 206-12
32. Roelands B, Meeusen R,. Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature. Sports Med. 2010; 40 (3): 229-46
33. Sara SJ,. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009 Mar; 10 (3): 211-23
34. Schule C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G,. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology. 2004; 29 (2): 185-200
35. Sidhu SK, Bentley DJ, Carroll TJ,. Locomotor exercise induces long-lasting impairments in the capacity of the human motor cortex to voluntarily activate knee extensor muscles. J Appl Physiol. 2009; 106 (2): 556-65
36. Søgaard K, Gandevia SC, Todd G, Petersen NT, Taylor JL,. The effect of sustained low-intensity contractions on supraspinal fatigue in human elbow flexor muscles. J Physiol. 2006; 573 (2): 511-23
37. Szabadi E,. Doxazosin for reboxetine-induced urinary hesitancy. Br J Psychiatry. 1998; 173: 441-2
38. Taylor JL, Todd G, Gandevia SC,. Evidence for a supraspinal contribution to human muscle fatigue. Clin Exp Pharmacol Physiol. 2006; 33 (4): 400-5
39. Todd G, Taylor JL, Gandevia SC,. Measurement of voluntary activation of fresh and fatigued human muscles using transcranial magnetic stimulation. J Physiol. 2003; 551 (Pt 2): 661-71
40. Wong EH, Sonders MS, Amara SG, Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry. 2000; 47 (9): 818-29